Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4559421
Max Phase: Preclinical
Molecular Formula: C43H65N15O14
Molecular Weight: 1016.08
Molecule Type: Unknown
Associated Items:
ID: ALA4559421
Max Phase: Preclinical
Molecular Formula: C43H65N15O14
Molecular Weight: 1016.08
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)O
Standard InChI: InChI=1S/C43H65N15O14/c1-7-22(4)34(40(65)53-28(17-25-18-47-20-49-25)41(66)56-13-9-11-29(56)38(63)50-23(5)42(67)68)55-37(62)27(14-24-15-30(57(69)70)35(60)31(16-24)58(71)72)52-39(64)33(21(2)3)54-36(61)26(51-32(59)19-46-6)10-8-12-48-43(44)45/h15-16,18,20-23,26-29,33-34,46,60H,7-14,17,19H2,1-6H3,(H,47,49)(H,50,63)(H,51,59)(H,52,64)(H,53,65)(H,54,61)(H,55,62)(H,67,68)(H4,44,45,48)/t22-,23+,26-,27-,28-,29-,33-,34-/m0/s1
Standard InChI Key: BHACHSPUZLQUAM-LUQQSYEESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1016.08 | Molecular Weight (Monoisotopic): 1015.4835 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2013) beta-arrestin effectors and compositions and methods of use thereof, |
Source(1):